Three brands. Same molecule. All “not tolerated.”
Every clinician has met this patient. Their file reads like a list of failed trials. They cannot tolerate three different brands of the same molecule. They react to one manufacturer’s product but not another’s. And so they get labelled: intolerant, non-adherent, or — least helpfully — anxious.
Before accepting that label, ask a simpler question.
What else is in the tablet?
Because a finished oral dosage form is mostly not active ingredient. It is diluent, binder, disintegrant, lubricant, coating, colourant, sweetener and preservative. Those are the excipients — and they are conventionally described as inert.
The seven worth committing to memory
The usual suspects are consistent across the drug-allergy literature. They are the first things to look for when a patient reports an unexplained reaction.
| Excipient class | Common examples | Patients at risk |
|---|---|---|
| Sugar-based diluents | Lactose — a very common tablet filler | Lactose intolerance; cow’s-milk protein allergy, where dairy-derived lactose may carry trace milk protein |
| Polymers / surfactants | Polyethylene glycol (PEG), polysorbate 80 | Urticarial and immediate hypersensitivity reactions reported; cross-reactivity between PEG and polysorbates is described |
| Colourants | Azo dyes such as tartrazine | Reported dye sensitivity; respiratory and cutaneous symptoms described |
| Preservatives | Parabens, benzyl alcohol, benzalkonium chloride | Liquid and topical preparations; paediatric and dermatology patients in particular |
| Cellulose derivatives | Carboxymethylcellulose (CMC) | Implicated in reactions to injectable and oral corticosteroid preparations |
| Cereal-derived starches | Wheat starch and related carriers | Coeliac disease and gluten sensitivity |
| Animal-derived materials | Gelatin | Gelatin allergy; also relevant to dietary and religious requirements |
The clinical point is not that these ingredients are dangerous. It is that they are invisible to the prescribing decision. You chose the active. You chose the dose. You never chose the filler.
Compounding gives that choice back — if you name the agent
1. Exclude the specific agent
The most direct instruction is an exclusion: prepare this without lactose; without dyes; without parabens; without gluten-containing carriers; without gelatin.
2. Change the dosage form entirely
Sometimes the cleanest way past an excipient problem is to leave the dosage form behind. A powder, an oral liquid, a suspension or a topical preparation can carry the same active with a far shorter excipient list than a coated, coloured, compressed tablet — and it solves the adjacent problem of patients who cannot swallow solid dose forms, without a second intervention.
3. Consolidate the regimen
Patients with multiple sensitivities often end up on several separate products, each with its own excipient profile and therefore its own risk. Where the actives are compatible, one compounded preparation can replace several — reducing the excipient burden and the adherence burden at the same time.
4. Consider the delivery vehicle on its merits
Where absorption or gastrointestinal tolerability has been the limiting factor, a liposomal preparation — the active carried within a phospholipid vesicle — may be appropriate. It is not automatically superior and should not be a default. Consider it when the active is poorly absorbed, unstable in the gut, or when conventional oral dosing has been poorly tolerated. That judgement stays with the prescriber.
Then ask the harder question: how do you keep it out?
An exclusion on a prescription is only as good as the bench behind it. Practitioners are entitled to ask a compounding pharmacy exactly how the exclusion is protected:
- Ingredient traceability. Every active and excipient sourced against documentation, so “lactose-free” is an evidenced statement rather than an assumption.
- Cross-contamination control. Equipment cleaning, segregation and workflow designed so an allergen excluded from a formula does not re-enter it from the bench.
- Good Compounding Practice (GCP). Documented procedures, trained personnel and batch records for every preparation.
- Formulation review. A pharmacist checking that removing an excipient has not compromised stability, uniformity or the beyond-use date.
- Documentation back to the prescriber. A record of what was included and what was excluded, so the exclusion is auditable and reproducible on refill.
The regulatory position — say it plainly
Frequently asked questions
Can a patient react to an excipient rather than the active ingredient?
Yes. Excipients are an under-recognised cause of hypersensitivity and intolerance reactions. A patient who reacts to three brands of the same molecule may be reacting to something those brands have in common that is not the active.
Which excipients most commonly cause reactions?
Most frequently implicated: lactose; polyethylene glycol (PEG) and polysorbate 80; azo dyes such as tartrazine; parabens and benzyl alcohol; carboxymethylcellulose (CMC); wheat-derived starches; and gelatin.
How should a prescriber write an excipient exclusion?
Name the specific agent — “without lactose”, “without azo dyes”, “without parabens”. A precise exclusion is a specification that can be honoured and documented. A general “hypoallergenic” instruction is not.
Do compounded supplements from Lynnity require a prescription?
Yes. Every compounded preparation, supplements included, is prepared only on a prescription from a registered doctor, under Good Compounding Practice (GCP). There is no direct-purchase route.
Is removing an excipient just a deletion from the formula?
No. Excipients often perform structural work — bulk, binding, disintegration, stability. Removing one requires a pharmacist to re-check stability, uniformity and the beyond-use date of the preparation.
Name the exclusion. We’ll formulate around it.
Lynnity compounds to a prescriber’s specification — actives, strengths, delivery form and excipient profile — under Good Compounding Practice, for a named patient, on a prescription from a registered doctor.